Pelvic Inflammatory Disease (PID) Among Women of Reproductive and Perimenopausal Age in Delta State, Nigeria: Prevalence, Symptoms, Risk Factors, Awareness, and Health-Seeking Behaviours; A Cross-Sectional Study

Authors

  • Udoji Godsday OGBUTOR Faculty of Basic Medical Sciences, Delta State University Abraka, Delta State, Nigeria Author
  • Uvietessivwi Oghenenyoren Gloria Faculty of Basic Medical Sciences, Delta State University Abraka, Delta State, Nigeria Author
  • Ogbutor Emeke Godson Faculty of Basic Medical Sciences, Delta State University Abraka, Delta State, Nigeria Author
  • Nwose Jephthah Junior Department of Internal Medicine, Federal Medical Centre Asaba, Delta State, Nigeria Author
  • Anastacia Ojimba Department of Internal Medicine, Federal Medical Centre Asaba, Delta State, Nigeria Author
  • Chukwuemeka Ephraim Department of Internal Medicine, Federal Medical Centre Asaba, Delta State, Nigeria Author
  • Ezunu Esther Department of Nursing Services, Federal Medical Centre Asaba, Delta State, Nigeria Author

DOI:

https://doi.org/10.64229/xmaq8x42

Keywords:

Pelvic inflammatory disease, Clinical assessment, Reproductive-aged women, Perimenopause, Prevalence, Awareness, Health-seeking behaviour, Delta State

Abstract

Background: Pelvic inflammatory disease (PID) is a major reproductive-health problem associated with tubal infertility, ectopic pregnancy, chronic pelvic pain and recurrent infection. Objective: To determine and compare the prevalence, symptoms, risk factors, awareness and health-seeking behaviours associated with PID among reproductive-age and perimenopausal women in Delta State, Nigeria. Methods: An analytical cross-sectional study was conducted among 400 women aged 18-55 years attending six selected public hospitals in Delta State between November 2024 and July 2025. Participants were classified as reproductive-age women (18-44 years) or perimenopausal women (45-55 years). Data were collected using a structured questionnaire, clinical examination and supportive laboratory or imaging investigations. Clinically supported PID was the primary outcome. Results: The study included 255 reproductive-age and 145 perimenopausal women. Overall PID prevalence was 31.0% (95% CI: 26.7%-35.7%), with prevalence of 28.6% and 35.2%, respectively; the difference was not statistically significant (p=0.174). Previous PID, previous sexually transmitted infection, inconsistent condom use, vaginal douching and previous uterine instrumentation were significant independent predictors. Awareness was lower among perimenopausal women, who also had more delayed healthcare seeking. Conclusion: PID constituted a substantial clinical burden in both groups. Reproductive stage was not an independent predictor after adjustment. Prevention and management should emphasise individual risk assessment, improved awareness, prompt clinical evaluation and timely treatment.

References

[1]Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines. MMWR Recommendations and Reports, 2021, 70(4), 1-187. DOI: 10.15585/mmwr.rr7004a1

[2]Mitchell CM, Anyalechi GE, Cohen CR, Haggerty CL, Manhart LE, Hillier SL. Etiology and diagnosis of pelvic inflammatory disease: Looking beyond gonorrhoea and chlamydia. Journal of Infectious Diseases, 2021, 224(Suppl 2), S29-S35. DOI: 10.1093/infdis/jiab067

[3]Cheng Y, Yan C, Feng J, Chen J, Luan T, Lu Q, et al. Global and regional impact of pelvic inflammatory disease in females across all age groups, 1990-2021, with projections to 2046: Findings from the 2021 Global Burden of Disease Study. International Journal of Women’s Health, 2026, 18, 82360. DOI: 10.2147/IJWH.S582360

[4]Chen PY, Wei JB, Guo SS, Jiang YH, Li XF, Liang LJ, et al. Global, regional, and national impact of pelvic inflammatory disease: changing landscape from 1990 to 2021. International Journal of Women’s Health, 2026, 18, 597831. DOI: 10.2147/IJWH.S597831

[5]Eze EM, Unegbu VN, Ezebialu CU, Nneji IR. Prevalence of microorganisms associated with pelvic inflammatory disease in reproductive-aged women in Onitsha North, Anambra State, Nigeria. Novel Research in Microbiology Journal, 2018, 2(6), 147-155. DOI: 10.21608/NRMJ.2018.22707

[6]Oyedum UM, Kuta FA, Saidu AN, Babayi H. A comparative study on the effects of various factors on the prevalence of pelvic inflammatory disease in North-Central Nigeria. African Journal of Pure and Applied Sciences, 2021, 2(2), 108-117. DOI: 10.33886/ajpas.v2i2.214

[7]Pépin J, Deslandes S, Khonde N, Kintin DF, Diakité S, Sylla M, et al. Low prevalence of cervical infections in women with vaginal discharge in West Africa: Implications for syndromic management. Sexually Transmitted Infections, 2004, 80(3), 230-235. DOI: 10.1136/sti.2003.007534

[8]Lidegaard O, Helm P. Pelvic inflammatory disease: the influence of contraceptive, sexual and social life events. Contraception, 1990, 41(5), 475-483. DOI: 10.1016/0010-7824(90)90057-3

[9]Wølner-Hanssen P, Eschenbach DA, Paavonen J, Stevens CE, Kiviat NB, Critchlow C, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA, 1990, 263(14), 1936–1941. DOI: 10.1001/jama.1990.03440140062032

[10]Centers for Disease Control and Prevention. About pelvic inflammatory disease (PID). 2023. Available at: https://www.cdc.gov/pid/about/ (Accessed on 23 August 2026).

[11]Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W Jr, Weström L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. American Journal of Obstetrics and Gynecology, 1993, 168(5), 1503-1509. DOI: 10.1016/S0002-9378(11)90790-X

[12]Gil Y, Capmas P, Tulandi T. Tubo-ovarian abscess in postmenopausal women: A systematic review. Journal of Gynecology Obstetrics and Human Reproduction, 2020, 49(9), 101789. DOI: 10.1016/j.jogoh.2020.101789

[13]Rabiu KA, Adewunmi AA, Akinlusi FM, Akinola OI. Female reproductive tract infections: Understandings and care-seeking behaviour among women of reproductive age in Lagos, Nigeria. BMC Women’s Health, 2010, 10, 8. DOI: 10.1186/1472-6874-10-8

[14]den Heijer CDJ, Hoebe CJPA, Driessen JHM, Wolffs P, van den Broek IVF, Hoenderboom BM, et al. Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy and female infertility: a retrospective cohort study among primary-care patients. Clinical Infectious Diseases, 2019, 69(9), 1517-1525. DOI: 10.1093/cid/ciz429

[15]Weström L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility: A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic findings. Sexually Transmitted Diseases, 1992, 19(4), 185-192.

[16]O Ogolodom MP, Onosakponome EO, Hulda HA, Nyenke CU, Okankwu EA, Achi GI, et al. Awareness and knowledge of pelvic inflammatory disease, its risk factors and diagnostic procedures among female undergraduates in tertiary institutions in Rivers State, Nigeria. Malaysian Journal of Microbiology, 2023, 19(1), 63-73. DOI: 10.21161/mjm.220027

[17]Charvériat A, Fritel X. Diagnosis of pelvic inflammatory disease: clinical, paraclinical, imaging and laparoscopy criteria. CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines. Gynecology Obstetrics Fertility and Senology, 2019, 47(5), 404-408. DOI: 10.1016/j.gofs.2019.03.010

[18]Wang R, Carson KA, Sao SS, Coleman JS. Association of neighbourhood economic status and race with developing pelvic inflammatory disease after sexually transmitted infections. Obstetrics and Gynecology, 2023, 142(4), 948-955. DOI: 10.1097/AOG.0000000000005341

[19]Jossens MO, Eskenazi B, Schachter J, Sweet RL. Risk factors for pelvic inflammatory disease: A case-control study. Sexually Transmitted Diseases, 1996, 23(3), 239-247. DOI: 10.1097/00007435-199605000-00014

[20]Trent M, Bass D, Ness RB, Haggerty C. Recurrent PID, subsequent STI and reproductive-health outcomes: Findings from the PID Evaluation and Clinical Health (PEACH) study. Sexually Transmitted Diseases, 2011, 38(9), 879-881. DOI: 10.1097/OLQ.0b013e31821f918c

[21]Hillier SL, Bernstein KT, Aral S. A review of the challenges and complexities in the diagnosis, etiology, epidemiology and pathogenesis of pelvic inflammatory disease. Journal of Infectious Diseases, 2021, 224(Suppl 2), S23-S28. DOI: 10.1093/infdis/jiab116

[22]Zhang J, Thomas AG, Leybovich E. Vaginal douching and adverse health effects: a meta-analysis. American Journal of Public Health, 1997, 87(7), 1207-1211. DOI: 10.2105/AJPH.87.7.1207

[23]Gondwe T, Ness R, Totten PA, Astete S, Tang G, Gold MA, et al. Novel bacterial-vaginosis-associated organisms mediate the relationship between vaginal douching and pelvic inflammatory disease. Sexually Transmitted Infections, 2020, 96(6), 439-444. DOI: 10.1136/sextrans-2019-054191

[24]Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Contraception, 2006, 73(2), 145-153. DOI: 10.1016/j.contraception.2005.08.007

[25]Farley TMM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet, 1992, 339(8796), 785-788. DOI: 10.1016/0140-6736(92)91904-M

[26]Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. New England Journal of Medicine, 2015, 372(21), 2039-2048. DOI: 10.1056/NEJMra1411426

[27]Frock-Welnak DN, Tam J. Identification and treatment of acute pelvic inflammatory disease and associated sequelae. Obstetrics and Gynecology Clinics of North America, 2022, 49(3), 551-579. DOI: 10.1016/j.ogc.2022.02.019

[28]Mili N, Paschou SA, Armeni A, Georgopoulos N, Goulis DG, Lambrinoudaki I. Genitourinary syndrome of menopause: A systematic review on prevalence and treatment. Menopause, 2021, 28(6), 706-716. DOI: 10.1097/GME.0000000000001752

[29]Ebong US, Makinde OA. Determinants of treatment-seeking behaviour for sexually transmitted infections in Nigeria. African Journal of Reproductive Health, 2021, 25(3), 105-112. DOI: 10.29063/ajrh2021/v25i3.12

[30]Ojifinni O, Ige O, Asuzu MC. Determinants of choice of health facility for reproductive morbidity by female traders in a Nigerian city. Annals of Ibadan Postgraduate Medicine, 2018, 16(1), 37-43. DOI: 10.4314/AIPM.V16I1

[31]Liu B, Donovan B, Hocking JS, Knox J, Silver B, Guy R. Improving adherence to guidelines for the diagnosis and management of pelvic inflammatory disease: a systematic review. Infectious Diseases in Obstetrics and Gynecology, 2012, 2012, 325108. DOI: 10.1155/2012/325108

Downloads

Published

2026-11-13

Issue

Section

Articles

How to Cite

OGBUTOR, U. G., Uvietessivwi Oghenenyoren Gloria, Ogbutor Emeke Godson, Nwose Jephthah Junior, Anastacia Ojimba, Chukwuemeka Ephraim, & Ezunu Esther. (2026). Pelvic Inflammatory Disease (PID) Among Women of Reproductive and Perimenopausal Age in Delta State, Nigeria: Prevalence, Symptoms, Risk Factors, Awareness, and Health-Seeking Behaviours; A Cross-Sectional Study. Nursing Science and Clinical Practice, 2(2), 1-14. https://doi.org/10.64229/xmaq8x42